- Home
- UPB vs FRPH Comparison
UPB vs FRPH Comparison
Compare UPB & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- FRPH
- Stock Information
- Founded
- UPB 2021
- FRPH 1986
- Country
- UPB United States
- FRPH United States
- Employees
- UPB N/A
- FRPH N/A
- Industry
- UPB
- FRPH Real Estate
- Sector
- UPB
- FRPH Finance
- Exchange
- UPB NYSE
- FRPH Nasdaq
- Market Cap
- UPB 521.3M
- FRPH 537.7M
- IPO Year
- UPB 2024
- FRPH N/A
- Fundamental
- Price
- UPB $10.93
- FRPH $26.86
- Analyst Decision
- UPB Strong Buy
- FRPH
- Analyst Count
- UPB 4
- FRPH 0
- Target Price
- UPB $56.50
- FRPH N/A
- AVG Volume (30 Days)
- UPB 411.4K
- FRPH 42.4K
- Earning Date
- UPB 08-14-2025
- FRPH 08-06-2025
- Dividend Yield
- UPB N/A
- FRPH N/A
- EPS Growth
- UPB N/A
- FRPH 12.32
- EPS
- UPB N/A
- FRPH 0.36
- Revenue
- UPB $2,296,000.00
- FRPH $31,576,000.00
- Revenue This Year
- UPB N/A
- FRPH N/A
- Revenue Next Year
- UPB N/A
- FRPH N/A
- P/E Ratio
- UPB N/A
- FRPH $76.85
- Revenue Growth
- UPB N/A
- FRPH 4.58
- 52 Week Low
- UPB $5.14
- FRPH $25.37
- 52 Week High
- UPB $29.46
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- FRPH 46.56
- Support Level
- UPB N/A
- FRPH $26.73
- Resistance Level
- UPB N/A
- FRPH $27.71
- Average True Range (ATR)
- UPB 0.00
- FRPH 0.59
- MACD
- UPB 0.00
- FRPH -0.01
- Stochastic Oscillator
- UPB 0.00
- FRPH 9.06
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).